USD
+$0.00
(+0.00%
)At Close (As of Oct 13, 2025)
$37.99M
Market Cap
-
P/E Ratio
-1.21
EPS
$11.35
52 Week High
$4.14
52 Week Low
HEALTHCARE
Sector
Field | Value (CNY) |
---|---|
Gross Profit | $829M |
Total Revenue | $14B |
Cost Of Revenue | $14B |
Costof Goods And Services Sold | $14B |
Operating Income | $2.1M |
Selling General And Administrative | $71M |
Research And Development | - |
Operating Expenses | $827M |
Investment Income Net | - |
Net Interest Income | -$21M |
Interest Income | $7M |
Interest Expense | $28M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $17M |
Income Before Tax | -$21M |
Income Tax Expense | $96K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$21M |
Comprehensive Income Net Of Tax | - |
Ebit | $7.7M |
Ebitda | $25M |
Net Income | -$65M |
Field | Value (CNY) |
---|---|
Total Assets | $2.8B |
Total Current Assets | $2.6B |
Cash And Cash Equivalents At Carrying Value | $462M |
Cash And Short Term Investments | $462M |
Inventory | $1.4B |
Current Net Receivables | $631M |
Total Non Current Assets | $138M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $1.4M |
Intangible Assets Excluding Goodwill | $1.4M |
Goodwill | - |
Investments | - |
Long Term Investments | $0 |
Short Term Investments | $0 |
Other Current Assets | $169M |
Other Non Current Assets | - |
Total Liabilities | $2.4B |
Total Current Liabilities | $2.3B |
Current Accounts Payable | $1.7B |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $201M |
Total Non Current Liabilities | $64M |
Capital Lease Obligations | $96M |
Long Term Debt | - |
Current Long Term Debt | $161M |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $257M |
Other Current Liabilities | $230M |
Other Non Current Liabilities | $9M |
Total Shareholder Equity | -$643M |
Treasury Stock | - |
Retained Earnings | -$3.9B |
Common Stock | $58K |
Common Stock Shares Outstanding | $8.6M |
Field | Value (CNY) |
---|---|
Operating Cashflow | $263M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $17M |
Capital Expenditures | $15M |
Change In Receivables | - |
Change In Inventory | $28M |
Profit Loss | - |
Cashflow From Investment | $37M |
Cashflow From Financing | -$406M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$21M |
Field | Value (CNY) |
---|---|
Gross Profit | $829M |
Total Revenue | $14B |
Cost Of Revenue | $14B |
Costof Goods And Services Sold | $14B |
Operating Income | $2.1M |
Selling General And Administrative | $71M |
Research And Development | - |
Operating Expenses | $827M |
Investment Income Net | - |
Net Interest Income | -$21M |
Interest Income | $7M |
Interest Expense | $28M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $17M |
Income Before Tax | -$21M |
Income Tax Expense | $96K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$21M |
Comprehensive Income Net Of Tax | - |
Ebit | $7.7M |
Ebitda | $25M |
Net Income | -$65M |
Sector: HEALTHCARE
Industry: MEDICAL DISTRIBUTION
111, Inc. is a leading integrated healthcare platform based in Shanghai, China, that adeptly combines online and offline services to cater to the growing healthcare needs of consumers in the region. By leveraging cutting-edge technology and a broad network of healthcare providers, the company streamlines access to healthcare products and services, enhancing the overall patient experience. As a key player in China's evolving healthcare market, 111, Inc. is well-positioned to capitalize on the increasing demand for digital healthcare solutions and improve healthcare delivery nationwide.